November, 2007 - Toshiba America Medical Systems showcased its Aquilion CT, Aplio XG ultrasound system, Virtual Explorer ...
November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's SIMCOR, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan, and simvastatin, met its primary endpoint of lowering plaque-promoting non-HDL cholesterol (total cholesterol minus HDL), while demonstrating improvements on other key lip
November 6, 2007 – Philips Medical Systems at AHA highlighted its recently introduced iE33 Live 3D TEE, an echo system ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
November, 2007 - An ECG that fits in the palm of your hand, Mortara Instrument’s ELI 10 hand-held electrocardiograph includes a variety of advanced clinical and communication features.
November 4, 2007 - Itamar Medical announced that four presentations at AHA, including one from the Framingham Heart ...
November 6, 2007 - Acusphere Inc. announced that Imagify Perfusion Stress Echo, an investigational new drug developed to ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
Pinyons Medical Technology offers the FDA-cleared PowrSyringe Injector, a disposable hand-held device designed to offer ergonomic and mechanical advantages to inject and aspirate fluids including use in angiography. The Injector’s crossing handles hinge to the syringe barrel and plunger to advance the plunger into the barrel when the handles are squeezed.
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
November 05, 2007
